Akari Therapeutics Current Deferred Revenue (Quarterly) Insights

Akari Therapeutics Plc (AKTX)

0.2655 0.00 (0.00%) USD | NASDAQ | Jan 22, 16:00

0.2757 +0.01 (+3.84%) After-Hours: 18:28

View Current Deferred Revenue (Quarterly) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

DBV Technologies SA	--
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	Upgrade
NuCana Plc	--
Autolus Therapeutics Plc	Upgrade